CHRS

0.36984.47%
AJ

Ali J. Satvat

Independent Director

Mr. Ali J. Satvat, Ph.D., is Partner, Global Head of Health Care Strategic Growth and Co-Head of Americas Private Equity Health Care Strategic Growth of Private Equity at KKR & Co. Inc from 2026. He serves as a Member of the Board of Managers of HCRx Holdings at Healthcare Royalty Management, LLC, and he is in this position since July 2025. He is Director of Treeline Biosciences, Inc. Mr. Satvat serves as Director of Digital Diagnostics Inc. since August 2022. He serves as Director of Cortex. He serves as Director at Paige.AI Inc. Mr. Satvat serves as Director at Sapphiros. He serves as Director of AcuFocus, Inc. and Clarify Health Solutions, Inc. He serves as Independent Board of Directors of IPI Legacy Liquidation Co formerly known as Impel Pharmaceuticals Inc. since December 2018. He has been Independent Director of BridgeBio Pharma, Inc. since March 2016. He serves on the boards of Directors of Blue Sprig Pediatrics. He serves as Chairman of the Board of Cohera Medical, Inc. He is a Member of Board of Director of Slayback Pharma, LLC. He serves as Director of Arbor Pharmaceuticals, LLC. He is an Independent Director of Coherus Oncology, Inc. since May 19, 2014 and Healthcare Private Equity Association since July 2014. Mr. Satvat serves or served in various Advisor and Board capacities to several companies including Aerovance, Esprit Pharma, MagnaCare, Prometheus Laboratories, SkinMedica and Voyager HospiceCare. At KKR & Co. Inc., he co-manages the Health Care industry team within the Americas Private Equity platform and serves as Global Head of the Health Care Strategic Growth platform. He is responsible for KKR's health care strategic growth investing efforts. He joined the KKR & Co. Inc. in 2012. He served as Partner of Private Equity and Head of Health Care Strategic Growth of KKR & Co. Inc. until 2026. He was Partner, Co-Head of Health Care industry team and Head of Health Care Strategic Growth of KKR & Co. Inc. He was Co-Head of Americas Health Care Private Equity and Global Head of Health Care Strategic Growth of KKR & Co. Inc. He was Director of Healthcare Private Equity of KKR & Co. Inc. from January 2012. He was Member of Private Equity of KKR & Co. Inc. He served as Director of Headlands Research Inc. until January 2026. He was the Director of Eidos Therapeutics, Inc. from June 2018 until January 26, 2021. He served as Director at PRA Health Sciences, Inc. from September 2013 to April 13, 2018. He was a Principal of Apax Partners LLP from 2006 to 2012, where he participated in many of its health care private equity and growth equity investments. Previously, Mr. Satvat held various positions with Johnson & Johnson Innovation - JJDC, Inc., Audax Group from 2002 to 2004 and The Blackstone Group from 2000 to 2002, where he was involved in a broad range of transactions. He joined Audax Group, Inc. in 2002. He served as an Analyst at The Blackstone Group L. P. in the mergers and acquisitions advisory group. He has served on multiple public and private boards of Directors, including Cordis, Geode Health, Paige. AI and Trilogy MedWaste. He served on the Board of Directors of Boston Sarl. He served as a Director of Chiron Holdings/Kinetic Concepts from 2011 to 2012 and TZ Holdings/The TriZetto Group from 2008 to 2012. Mr. Satvat received an M. B. A. in Health Care Management and Entrepreneurial Management from the Wharton School of the University of Pennsylvania and an A. B., magna cum laude, in History and Science from Harvard College.

Positions